Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr.Vaccaro N is currently working in Senior Clinical Pharmacology Scientist / Technology, Process, Infrastructure Lead at Janssen, Pharmaceutical Companies of Johnson and Johnson.Had experience in the pharmaceutical industry, specifically in Phase I clinical trials, and currently pursuing an advanced degree in Regulatory Affairs for Drugs, Biologics, and Medical Devices. Therapeutic areas of experience include, cardiovascular/metabolism, oncology, infectious diseases, women's health, and immunology. Experience in over 100+ clinical trials in all phases of drug development conducted in numerous study populations. Responsible Scientist in the successful submissions of INVOKANA and DORIBAX, and contributor to a number of other regulatory submissions.
Clinical trials, Drug regulatory affairs,Cardiovascular/metabolism, oncology, Infectious diseases, women's health, Immunology.
Bioequivalence of Canagliflozin/Metformin Immediate Release Fixed- Dose Combination Tablets Compared with Concomitant Administration of Single Components of Canagliflozin and Metformin in Healthy Fed Participants
Devineni D, Curtin CR, Ariyawansa J, Weiner S, Stieltjes H, Vaccaro N, Shalayda K, Murphy J, DiProspero NA and Wajs E
Research Article: J Bioequiv Availab